Burn recovery study to improve sepsis prediction
Part of Infections, Injuries & trauma, Lungs & breathing clinical trials.
This study collects tissue and data from burn patients to build a better tool for predicting sepsis, a serious infection. If you qualify, your participation could help improve care for future burn patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a burn covering more than 10% of your body surface area.
- You are between 18 and 80 years old.
- You are being treated at a participating hospital (Emory/Grady, USF, or USAISR).
- You or your legal representative can understand the study and give permission (consent).
- You are not pregnant, a prisoner, or under 18.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the TDAP vaccine (tetanus, diphtheria, and pertussis) helps adults with serious burns. It aims to see if the vaccine can improve recovery or prevent infections.
This study looks at abnormal immune cells (from the bone marrow) in people with sepsis or severe trauma with shock. It aims to understand why the body’s immune response gets out of balance, which could help guide future treatments.
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.